Congenital coronary arteriovenous fistulas (CCAFs) are rare coronary artery abnormalities in which blood is shunted into a cardiac chamber or great vessel. If the fistula itself is large and tortuous, it is generally recommended to occlude the fistula to prevent several complications. In approaches of transcatheter occlusion, the transvenous approach is preferred over the transarterial approach. The transvenous approach would enable the cannulation of a relatively larger catheter or sheath without potential damage to the femoral vessels or normal coronary arteries, which can occur in the transarterial approach. The transvenous approach may also minimize the blind pouch after releasing the devices. Herein, we report the success of transvenous proximal closure of a CCAF using an Amplatzer vascular plug (AVP) in a 3-year-old patient with cardiomegaly. Complete occlusion was achieved by a single AVP and thrombus formation of the distal aneurysmal portion of the fistula. We suggest that this strategy of closing the proximal end with a dilated fistula using a single AVP by the transvenous approach may be a good option in treating CCAFs in a young child.
Introduction
Congenital coronary arteriovenous fistulas (CCAFs) are rare coronary artery abnor malities in which blood is shunted into a cardiac chamber or great vessel. The clinical features, which depend on the size and location of these fistulas, range from a conti nuous murmur to congestive heart failure. Although small fistulas may be closed spon taneously, larger or symptomatic fistulas may be considered for either surgical or transcatheter correction to prevent complications and progressive nature 1) . Recently, inter ventional occlusion of CCAFs has emerged as a wellaccepted alternative to surgery using various devices including detachable balloons, different types of coils, the Am plantzer duct occluder and the Amplatzer vascular plug (AVP) 2, 3) . If the fistula itself is large and tortuous, it is generally recommended to occlude both side of the fistula with devices 4) . In approaches of transcatheter occlusion, the transarterial approach is an easier access than transveous. However, it may damage normal coronary artery and the mitral valve, especially in children. In contrast, the transvenous approach would enable cannulation of a relatively large catheter or sheath without causing potential damage to the femoral vessels or normal coronary arteries, and would enable release of the device, minimizing the blind pouch 5) . We report the success of transvenous proximal embolization of a CCAF using single AVP in a 3yearold child with cardiomegaly.
Case report
A 3yearold girl, weighing 17 kg, was referred to Chonnam National University Hospital for evaluation of cardiomegaly. At 2month of her age, the patient was evaluated for heart murmur and was diagnosed with CCAF. Because she did not show any symptoms of heart failure, medication was not given and serial echocardiography performed. On physical examination, grade 2/6 continuous murmur at the left lower sternal border was heard and she had no previous symptoms of tachypnea, poor feeding, cold sweat, cyanosis, etc. Chest radiography revealed cardiomegaly with normal pulmonary vascular markings (Fig.  1) . Resting electrocardiogram (ECG) showed mild right ventricular hypertrophy and artery pres sures were 90 mmHg systolic and 50 mmHg diastolic. Twodimension and color Doppler ECG showed a coronary artery fistula arising from a dilated right coronary artery (RCA) and draining into the right atrium through the aneurysmal sac in the right atrium ( Fig. 2A) . Computed tomography showed an approxi mately 21×16 mm aneurysmal dilatation in a dilated sinoatrial nodal branch of the RCA, and a fistula was located between the distal portion of the aneurysmal sac and right atrium (Fig. 2B) .
After parental informed consent, cardiac catheterization was performed. The right femoral vein and artery were cannu lated and the patient was heparinized intravenously (50 IU/kg). A RCA angiogram revealed a dilated proximal RCA and 4 mm sized coronary fistula originating from the proximal portion of the RCA emptying into the right atrium with an aneurysm having a maximal diameter of 23 mm; the sizes of the right marginal branch and RAC (originating distal to the fistula) were normal (Fig. 2C) . After an unsuccessful attempt to guide the wire loop through the extensively tortuous fistula, we de cided to change the approach to a transvenous approach. A Progreat 0.019 inch microcatheter (Terumo, Tokyo, Japan) was introduced into the right atrium through the right femoral vein, passing the aneurysm sac, coronary fistula, RCA and ascending aorta. A 0.014 inch runthrough wire (Terumo) was inserted along with the Progreat wire and was replaced with a 4F multipurpose catheter. It was then placed with its tip at the proximal coronary fistula. An 8mm AVP, which is ap proximately twice as large as the diameter of the proximal fistula, was inserted and placed immediately proximal to the coronary fistula (at its origin from the normal RCA) in order to minimize the "blind pouch."
After confirmation of the correctly positioned AVP by a RCA angiogram without evidence of ischemic changes in an ECG, the device was released. In repeated RCA angiography 10 minutes after AVP insertion, no shunt lesion was noted (Fig. 3) . A repeat echocardiography 3 days after intervention showed no shunt, although the fistula and thrombus were formed in the distal aneurysmal portion of the fistula (Fig. 4A) . We did not attempt to occlude the distal fistula with another device anymore because distal portion was already naturally closed by the thrombus. The followup chest posteroanterior view showed decreased heart size after the procedure.
The patient was prescribed aspirin 3 mg/kg daily for 6 months to prevent thromboembolic events. Followup echo cardiography at 1, 3, 6 months and 1 year after the procedure showed a decreasing size of aneurysm of fistula with thrombus for mation (Fig. 4B) . The patient remained completely asympto matic including no thromboemboic event during the followup period of 1 year and 4 months.
Discussion
CCAFs are uncommon diseases and most are asymptomatic in infancy. However, their progressive nature and potential complications are sometimes fatal to patients 1, 6) . Therefore, occlusion of symptomatic CCAF and asymptomatic CCAF with high flow shunting has been generally recommended 7) .
Transcatheter closure is preferred over open surgery because it is less invasive and requires less recovery time. Reports have described catheterbased occlusion using a variety of techniques and devices 4) . Coils are used for small size of fistula, however, they are not eligible when CCAF is large and has complex anatomy, and there are also the possibility of multiple coil im plantations for complete occlusion, which can increase the risk of coil embolization 8) . An Amplantzer duct occluder is used for larger CCAF, which is relatively easy to control and there is no need to implant multiple devices. However, it requires a relatively larger delivery catheter that can be difficult when confronted by tortuous fistulas 9) . Recently, AVP has been con sidered for larger and more tortuous fistulas. It is easy to deliver and has a wide range of device sizes. An operator could per form an angiography by the side arm of a TuohyBorst connection. This enables more precise positioning. Also its' retrieval decreases the risk of obstruction and migration 10) . Transarterial or transvenous approaches are used to occlude CCAFs. If the fistulous orifice is easy to access, the transvenous approach is preferred. This would enable the cannulation of a relatively large catheter or sheath deeply without causing potential damage to the femoral artery or normal coronary artery, and would facilitate release of the device minimizing the blind pouch. However, it is almost impossible to enter a CCAF when the fistula is extensively tortuous. When the ca theter cannot be delivered directly to the fistulous orifice, the arteriovenous loop formation is warranted 11) . The use of an arteriovenous wire loop delivers the devices through very small catheters and sheaths, and avoids potential damage to the femoral artery. However, it has a risk of damage to the arteriovenous valve 5) . In our case, our initial attempt to make an arteriovenous wire loop or transarterial approach was unsuccessful, which forced us to use the transvenous approach. Consequently, the blind pouch was minimized by the alternative approach. If the fistula itself is large and tortuous, it is generally recommended that the fistula be closed from both sides with devices 4) . On report described a case with fistula occlusion by proximal and distal devices. The authors first used three Gianturco coils placed in the distal bulbous portion of the fistula, followed by an AVP placed in the most proximal part of the fistula to ensure the obliteration of the blind pouch 12) . Another study reported a failed attempt to close a large fistula by a distal implant of AVP. These authors implanted another AVP proximal segment of the fistula 9) . However, these procedures by transarterial approach have a potential, ambivalent risk of making a "blind pouch" with minimal invasion of coronary artery or invasion of normal coronary artery with minimal "blind pouch." In our case, the fistula was a relatively large (4 mm), long and tortuous aneurysmal sac (23 mm) arising close to the right atrial end. Initially, we decided to deliver AVP to the proximal part of the fistula and then placed another AVP distal to the distal aneurysmal sac. After the former AVP was deployed in the proximal fistula, RCA angiography documented complete fistula occlusion at the AVP level without significant residual shunt. Thus, there was no necessity to implant another AVP. Consequently, the thrombus formation occurred in the distal aneurysmal sac after proximal fistula occlusion by a single AVP.
We propose that the spontaneous thrombus formation in distal aneurismal sac likely resulted from the placement of the AVP in such a way that it reduced the velocity of blood flow and thrombogenic condition due to vascular irritation when the guide wire passed the aneurysmal sac. Although there was a risk of thrombus embolization after closure, that does not appear to have occurred, and the aneurysmal sac and fistula decreased in size with time.
We report the success of transvenous proximal closure of a CCAF using AVP in a 3yearold patient with cardiomegaly. Complete occlusion was achieved by a single AVP and thrombus formation of distal aneurysmal portion of the fistula. To our best knowledge, this is the youngest reported case using AVP with transvenous approach in South Korea. We suggest that this strategy of closing the proximal end with dilated fistula using single AVP by the transvenous approach can be a good option in treating CCAFs in young child.
